- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-28
DOI
10.3389/fimmu.2021.755333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID‐19‐associated cutaneous manifestations: does HHV‐6 play an etiological role?
- (2021) I. Abadías‐Granado et al. BRITISH JOURNAL OF DERMATOLOGY
- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
- (2021) Christina Krienke et al. SCIENCE
- Immunological characteristics govern the transition of COVID-19 to endemicity
- (2021) Jennie S. Lavine et al. SCIENCE
- The Choroid Plexus Is Permissive for a Preactivated Antigen-Experienced Memory B-Cell Subset in Multiple Sclerosis
- (2021) Jürgen Haas et al. Frontiers in Immunology
- Vaccinations in multiple sclerosis patients receiving disease-modifying drugs
- (2021) Susana Otero-Romero et al. CURRENT OPINION IN NEUROLOGY
- Acute hemorrhagic leukoencephalitis in a COVID-19 patient—a case report with literature review
- (2021) Baskaran Varadan et al. NEURORADIOLOGY
- Acute myelopathies associated to SARS-CoV-2 infection: Viral or immune-mediated damage?
- (2021) Isabella Canavero et al. Travel Medicine and Infectious Disease
- A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis
- (2021) Abdorreza Naser Moghadasi AUTOIMMUNITY REVIEWS
- COVID-19, HHV6 and MOG antibody: A perfect storm
- (2021) Muruj Jumah et al. JOURNAL OF NEUROIMMUNOLOGY
- Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
- (2021) Diego Centonze et al. JOURNAL OF NEUROLOGY
- Epstein-Barr virus lytic replication induces ACE2 expression and enhances SARS CoV-2 pseudotyped virus entry in epithelial cells
- (2021) Dinesh Verma et al. JOURNAL OF VIROLOGY
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- Post-acute COVID-19 syndrome
- (2021) Ani Nalbandian et al. NATURE MEDICINE
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
- (2021) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
- (2021) Matija Zelic et al. Cell Reports
- Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review
- (2021) Luis Alberto Rodríguez de Antonio et al. Multiple Sclerosis and Related Disorders
- COVID-19 in a temporal relation to the onset of multiple sclerosis
- (2021) Yara D. Fragoso et al. Multiple Sclerosis and Related Disorders
- Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)
- (2021) Gustavo C. Román et al. Frontiers in Immunology
- Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients
- (2021) Emanuela Balestrieri et al. EBioMedicine
- COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?
- (2021) Abdorreza Naser Moghadasi AUTOIMMUNITY REVIEWS
- Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
- (2021) Itay Lotan et al. EUROPEAN JOURNAL OF NEUROLOGY
- Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions
- (2021) Marius Schwabenland et al. IMMUNITY
- First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
- (2021) Joachim Havla et al. JOURNAL OF NEUROLOGY
- Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience
- (2021) Guerrieri S. et al. JOURNAL OF NEUROLOGY
- Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study
- (2021) Hans-Peter Hartung et al. Multiple Sclerosis Journal
- SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study
- (2021) Maria Pia Sormani et al. Multiple Sclerosis Journal
- Dysregulation of brain and choroid plexus cell types in severe COVID-19
- (2021) Andrew C. Yang et al. NATURE
- The multiple sclerosis prodrome
- (2021) Naila Makhani et al. Nature Reviews Neurology
- Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
- (2021) Antonio Gallo et al. NEUROLOGICAL SCIENCES
- Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection
- (2021) K. Bigaut et al. REVUE NEUROLOGIQUE
- Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
- (2021) Nir Drayman et al. SCIENCE
- Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome
- (2021) Anthony L. Komaroff et al. TRENDS IN MOLECULAR MEDICINE
- Positive Epstein–Barr virus detection in coronavirus disease 2019 (COVID-19) patients
- (2021) Ting Chen et al. Scientific Reports
- COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
- (2021) Fabio Buttari et al. Multiple Sclerosis and Related Disorders
- COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
- (2021) Masoud Etemadifar et al. Multiple Sclerosis and Related Disorders
- COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
- (2021) Afagh Garjani et al. Multiple Sclerosis and Related Disorders
- Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: A case-control study
- (2021) William L. Conte Multiple Sclerosis and Related Disorders
- Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
- (2021) Christina Woopen et al. Frontiers in Immunology
- DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France
- (2021) Maria Pia Sormani et al. Annals of Clinical and Translational Neurology
- SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
- (2021) Daryl Geers et al. Science Immunology
- COVID-19 Among Patients With Multiple Sclerosis
- (2021) Mahdi Barzegar et al. Neurology-Neuroimmunology & Neuroinflammation
- Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies
- (2021) Kévin Bigaut et al. Neurology-Neuroimmunology & Neuroinflammation
- MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
- (2021) Rosella Mechelli et al. Microorganisms
- The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patients
- (2020) Yan‐Chao Li et al. JOURNAL OF MEDICAL VIROLOGY
- Inflammation of the choroid plexus in progressive multiple sclerosis: accumulation of granulocytes and T cells
- (2020) Sabela Rodríguez-Lorenzo et al. Acta Neuropathologica Communications
- SARS-CoV-2 can induce brain and spine demyelinating lesions
- (2020) Luca Zanin et al. ACTA NEUROCHIRURGICA
- Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology
- (2020) R. Ross Reichard et al. ACTA NEUROPATHOLOGICA
- NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
- (2020) Sunny Malhotra et al. BRAIN
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- A Dynamic Immune Response Shapes COVID-19 Progression
- (2020) Eugenia Ziying Ong et al. Cell Host & Microbe
- Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
- (2020) Tao Zuo et al. GASTROENTEROLOGY
- Respiratory virus infections: Understanding COVID-19
- (2020) Kanta Subbarao et al. IMMUNITY
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features
- (2020) Neo Poyiadji et al. RADIOLOGY
- SARS-CoV-2 productively infects human gut enterocytes
- (2020) Mart M. Lamers et al. SCIENCE
- Acute disseminated encephalomyelitis after SARS-CoV-2 infection
- (2020) Giovanni Novi et al. Neurology-Neuroimmunology & Neuroinflammation
- COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia
- (2020) Luke Dixon et al. Neurology-Neuroimmunology & Neuroinflammation
- The Role of TH17 Cells in Multiple Sclerosis: Therapeutic Implications
- (2020) Tobias Moser et al. AUTOIMMUNITY REVIEWS
- The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
- (2020) Ross W Paterson et al. BRAIN
- The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications
- (2020) Franco Scaldaferri et al. INFLAMMATORY BOWEL DISEASES
- An Italian programme for COVID-19 infection in multiple sclerosis
- (2020) Maria Pia Sormani LANCET NEUROLOGY
- A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: Potential implications for the SARS-CoV-2 modus operandi
- (2020) George D. Vavougios MEDICAL HYPOTHESES
- Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
- (2020) Amit Bar-Or et al. NEUROLOGY
- The Gut–CNS Axis in Multiple Sclerosis
- (2020) Atsushi Kadowaki et al. TRENDS IN NEUROSCIENCES
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
- (2020) Sara De Biasi et al. Nature Communications
- Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab
- (2020) Kulachanya Suwanwongse et al. Multiple Sclerosis and Related Disorders
- COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
- (2020) Giovanni Novi et al. Multiple Sclerosis and Related Disorders
- Severe COVID-19: NLRP3 Inflammasome Dysregulated
- (2020) Daan F. van den Berg et al. Frontiers in Immunology
- Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
- (2020) Martina Severa et al. Frontiers in Immunology
- Targeting the NLRP3 Inflammasome in Severe COVID-19
- (2020) Tracey L. Freeman et al. Frontiers in Immunology
- COVID-19 outcomes in MS
- (2020) Erica Parrotta et al. Neurology-Neuroimmunology & Neuroinflammation
- Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2–associated encephalitis
- (2020) Marta Bodro et al. Neurology-Neuroimmunology & Neuroinflammation
- Neuromyelitis optica spectrum disorder secondary to COVID-19
- (2020) Victoria C Shaw et al. BRITISH JOURNAL OF HOSPITAL MEDICINE
- The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
- (2020) Camila Rosat Consiglio et al. CELL
- Effects of COVID-19 on the Nervous System
- (2020) Costantino Iadecola et al. CELL
- Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)
- (2020) Conor N. Gruber et al. CELL
- Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis and Myelitis in COVID-19
- (2020) Siwei Zhou et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection
- (2020) Fabio Giuseppe Masuccio et al. JOURNAL OF NEUROLOGY
- Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
- (2020) Kumari G. Lokugamage et al. JOURNAL OF VIROLOGY
- COVID-19 related stroke in young individuals
- (2020) Johanna T Fifi et al. LANCET NEUROLOGY
- Vaccinations in patients with multiple sclerosis: A Delphi consensus statement
- (2020) Agostino Riva et al. Multiple Sclerosis Journal
- COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence?
- (2020) Diogo Goulart Corrêa et al. Multiple Sclerosis Journal
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Covid-19-associated acute haemorrhagic leukoencephalomyelitis
- (2020) Rahul Handa et al. NEUROLOGICAL SCIENCES
- Stroke Risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases
- (2020) Sebastian Fridman et al. NEUROLOGY
- Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
- (2020) David E. Gordon et al. SCIENCE
- Neuropilin-1 is a host factor for SARS-CoV-2 infection
- (2020) James L. Daly et al. SCIENCE
- Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
- (2020) Ludovico Cantuti-Castelvetri et al. SCIENCE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Evasion of Type I Interferon by SARS-CoV-2
- (2020) Hongjie Xia et al. Cell Reports
- A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors
- (2020) Manvendra Singh et al. Cell Reports
- A case of possible atypical demyelinating event of the central nervous system following COVID-19
- (2020) Anahita Zoghi et al. Multiple Sclerosis and Related Disorders
- Multiple sclerosis following SARS-CoV-2 infection
- (2020) M. Palao et al. Multiple Sclerosis and Related Disorders
- Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients
- (2020) Eric M. Liotta et al. Annals of Clinical and Translational Neurology
- High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
- (2020) Christiana Franke et al. BRAIN BEHAVIOR AND IMMUNITY
- COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response
- (2020) Ana Zabalza et al. EUROPEAN JOURNAL OF NEUROLOGY
- Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM)
- (2020) Omar Hussein et al. JOURNAL OF NEUROIMMUNOLOGY
- Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community
- (2020) Tissa Wijeratne et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial
- (2020) Bardia Nourbakhsh et al. LANCET NEUROLOGY
- The role of infections in multiple sclerosis
- (2019) Mariano Marrodan et al. Multiple Sclerosis Journal
- Prodrome in relapsing-remitting and primary progressive multiple sclerosis
- (2019) J. M. A. Wijnands et al. EUROPEAN JOURNAL OF NEUROLOGY
- Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis
- (2019) Jaine LS Soares et al. Multiple Sclerosis and Related Disorders
- Expression of HERV Genes as Possible Biomarker and Target in Neurodegenerative Diseases
- (2019) Antonina Dolei et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- (2019) Jacqueline M. Cliff et al. Frontiers in Immunology
- Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
- (2019) Kjetil Bjornevik et al. JAMA Neurology
- Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism
- (2019) Barbara Serafini et al. JOURNAL OF VIROLOGY
- Mounting evidence for a multiple sclerosis prodrome
- (2019) Ruth Ann Marrie Nature Reviews Neurology
- Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test
- (2019) Cara Tomas et al. Scientific Reports
- Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis
- (2019) Elin Engdahl et al. Frontiers in Immunology
- Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
- (2019) Amit Bar-Or et al. TRENDS IN MOLECULAR MEDICINE
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Multiple Sclerosis: Mechanisms and Immunotherapy
- (2018) Clare Baecher-Allan et al. NEURON
- Postinfectious Anti–Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis
- (2017) J. P. Vieira et al. JOURNAL OF CHILD NEUROLOGY
- The neurodegenerative prodrome in multiple sclerosis
- (2017) Gavin Giovannoni LANCET NEUROLOGY
- A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
- (2017) Gerwyn Morris et al. MOLECULAR NEUROBIOLOGY
- Multiple sclerosis: an example of pathogenic viral interaction?
- (2017) Walter Fierz Virology Journal
- High frequency of intestinal T H 17 cells correlates with microbiota alterations and disease activity in multiple sclerosis
- (2017) Ilaria Cosorich et al. Science Advances
- Fatigue in Multiple Sclerosis: Mechanisms, Evaluation, and Treatment
- (2017) Tiffany J. Braley et al. SLEEP
- Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells
- (2016) Ying Wang et al. JOURNAL OF CELL SCIENCE
- IFN-β and multiple sclerosis: From etiology to therapy and back
- (2015) V. Annibali et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
- (2015) Lazaros Belbasis et al. LANCET NEUROLOGY
- Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis
- (2015) Maria Kneider et al. NEUROEPIDEMIOLOGY
- Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells
- (2015) Hong-Bo Wang et al. Nature Communications
- Association Between Vaccines and Neuroinflammation
- (2015) Giovanni Ristori et al. JAMA Neurology
- Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation
- (2015) Andrew J. Steelman Frontiers in Immunology
- EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy
- (2015) Vito A. G. Ricigliano et al. PLoS One
- CD8+MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis
- (2014) Anne Willing et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
- (2014) Annette Langer-Gould et al. JAMA Neurology
- Noise in multiple sclerosis: unwanted and necessary
- (2014) Isabella Bordi et al. Annals of Clinical and Translational Neurology
- Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics
- (2013) Gerwyn Morris et al. BMC Medicine
- Fatigue heralding multiple sclerosis
- (2013) Joseph R Berger et al. Multiple Sclerosis Journal
- A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
- (2013) Rosella Mechelli et al. PLoS One
- Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
- (2013) Daniela F. Angelini et al. PLoS Pathogens
- CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
- (2011) Viviana Annibali et al. BRAIN
- Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
- (2011) Greta Guarda et al. IMMUNITY
- Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis
- (2011) Benjamin D. Solomon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Viral triggers of multiple sclerosis
- (2010) Kristina Kakalacheva et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Epstein–Barr Virus Infection and Multiple Sclerosis: A Review
- (2010) Alberto Ascherio et al. Journal of Neuroimmune Pharmacology
- Relapse Management in Multiple Sclerosis
- (2008) Ben W. Thrower NEUROLOGIST
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation